WallStreetZenWallStreetZen

NASDAQ: ATHE
Alterity Therapeutics Ltd Stock Forecast, Predictions & Price Target

Analyst price target for ATHE

Based on 1 analyst offering 12 month price targets for Alterity Therapeutics Ltd.
Min Forecast
$4.00+86.92%
Avg Forecast
$4.00+86.92%
Max Forecast
$4.00+86.92%

Should I buy or sell ATHE stock?

Based on 1 analyst offering ratings for Alterity Therapeutics Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ATHE stock forecasts and price targets.

ATHE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-07

1 of 1

ATHE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATHE$2.14$4.00+86.92%Buy
MNPR$0.68$2.00+194.99%Strong Buy
ERNA$2.15N/AN/A
MIRA$0.84N/AN/A
AVTX$12.01$35.00+191.42%Buy

Alterity Therapeutics Stock Forecast FAQ

Is Alterity Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ATHE) stock is to Buy ATHE stock.

Out of 1 analyst, 0 (0%) are recommending ATHE as a Strong Buy, 1 (100%) are recommending ATHE as a Buy, 0 (0%) are recommending ATHE as a Hold, 0 (0%) are recommending ATHE as a Sell, and 0 (0%) are recommending ATHE as a Strong Sell.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.

What is ATHE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ATHE price target, the average ATHE price target is $4.00, with the highest ATHE stock price forecast at $4.00 and the lowest ATHE stock price forecast at $4.00.

The Wall Street analyst predicted that Alterity Therapeutics's share price could reach $4.00 by Mar 7, 2025. The average Alterity Therapeutics stock price prediction forecasts a potential upside of 86.92% from the current ATHE share price of $2.14.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.